DE69600253T2 - Ein 4-Imidazolinon-Derivat und deren Verwendung als NMDA-Rezeptor-Agonist - Google Patents

Ein 4-Imidazolinon-Derivat und deren Verwendung als NMDA-Rezeptor-Agonist

Info

Publication number
DE69600253T2
DE69600253T2 DE69600253T DE69600253T DE69600253T2 DE 69600253 T2 DE69600253 T2 DE 69600253T2 DE 69600253 T DE69600253 T DE 69600253T DE 69600253 T DE69600253 T DE 69600253T DE 69600253 T2 DE69600253 T2 DE 69600253T2
Authority
DE
Germany
Prior art keywords
receptor agonist
nmda receptor
imidazolinone derivative
imidazolinone
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69600253T
Other languages
English (en)
Other versions
DE69600253D1 (de
Inventor
Alex Cordi
Jean-Michel Lacoste
Mark Millan
Valerie Audinot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Publication of DE69600253D1 publication Critical patent/DE69600253D1/de
Application granted granted Critical
Publication of DE69600253T2 publication Critical patent/DE69600253T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69600253T 1995-12-21 1996-12-09 Ein 4-Imidazolinon-Derivat und deren Verwendung als NMDA-Rezeptor-Agonist Expired - Fee Related DE69600253T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9515223A FR2742748B1 (fr) 1995-12-21 1995-12-21 Nouveau derive de 4-imidazolidinone, son procede de preparation et les compositions pharmaceutiques qui le contiennent

Publications (2)

Publication Number Publication Date
DE69600253D1 DE69600253D1 (de) 1998-05-28
DE69600253T2 true DE69600253T2 (de) 1998-11-12

Family

ID=9485771

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69600253T Expired - Fee Related DE69600253T2 (de) 1995-12-21 1996-12-09 Ein 4-Imidazolinon-Derivat und deren Verwendung als NMDA-Rezeptor-Agonist

Country Status (14)

Country Link
US (1) US5677325A (de)
EP (1) EP0780379B1 (de)
JP (1) JPH09176128A (de)
CN (1) CN1067381C (de)
AT (1) ATE165349T1 (de)
AU (1) AU705695B2 (de)
CA (1) CA2193310C (de)
DE (1) DE69600253T2 (de)
DK (1) DK0780379T3 (de)
ES (1) ES2118664T3 (de)
FR (1) FR2742748B1 (de)
NO (1) NO305753B1 (de)
NZ (1) NZ299984A (de)
ZA (1) ZA9610804B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6347197B1 (en) * 2000-10-20 2002-02-12 Lexmark International, Inc. Life determination in an oil web system
JP3891484B2 (ja) * 2002-09-05 2007-03-14 株式会社ノリタケカンパニーリミテド 電解質膜およびその膜を備えた燃料電池

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904681A (en) * 1987-12-01 1990-02-27 G. D. Searle & Co. D-cycloserine and its prodrugs as cognitive enhancers

Also Published As

Publication number Publication date
NO305753B1 (no) 1999-07-19
NO965445D0 (no) 1996-12-18
CN1067381C (zh) 2001-06-20
CA2193310A1 (fr) 1997-06-22
DE69600253D1 (de) 1998-05-28
ES2118664T3 (es) 1998-09-16
NZ299984A (en) 1997-11-24
CA2193310C (fr) 2001-08-14
EP0780379B1 (de) 1998-04-22
CN1158847A (zh) 1997-09-10
AU7547996A (en) 1997-06-26
NO965445L (no) 1997-06-23
FR2742748A1 (fr) 1997-06-27
ZA9610804B (en) 1997-06-30
DK0780379T3 (da) 1999-01-25
ATE165349T1 (de) 1998-05-15
FR2742748B1 (fr) 1998-01-30
EP0780379A1 (de) 1997-06-25
US5677325A (en) 1997-10-14
AU705695B2 (en) 1999-05-27
JPH09176128A (ja) 1997-07-08

Similar Documents

Publication Publication Date Title
EA199800318A1 (ru) Соединение, усиливающее активность ретиноидов
DK0776324T3 (da) Endothelin-antagonister
LV10864A (lv) Triazinu atvasinajumi to iegusanas panemiens un herbicids kas tos iesledz sevi ka aktivu ingredientu
ATE121730T1 (de) N-aryl und n-heteroarylamide und harnstoffderivate als inhibitoren von acyl- coenzym a: cholesterol-acyl-transferase.
DE69534768D1 (de) 8-(2,2,2-Trifluoroethyl)-8-azabicycloÄ3.2.1Üoctan-3-on verwendbar als Zwischenprodukt für Serotonin-4-Rezeptor stimulierende Chinolincarbonsäure-Derivate
DK0559898T3 (da) Anilidderivater
DE69600253D1 (de) Ein 4-Imidazolinon-Derivat und deren Verwendung als NMDA-Rezeptor-Agonist
ATE47857T1 (de) Substituierte 4-benzyl-piperazinyl-verbindungen.
DE69327890D1 (de) Verfahren zur Herstellung von 2-(un)substituierten 4-Alkylimidazolen
DE60025171D1 (de) 1-acyl-7-nitroindolin derivate, deren herstellung und deren verwendung als photospaltbare vorstufen
DE50112409D1 (de) Paraaminophenol-derivate und deren verwendung als entwickler zur erzeugung von oxidationsfaerbungen
DE69615570D1 (de) Verfahren zur herstellung von carbamoylmethylharnstoff-derivaten
DE59814233D1 (de) Indolmethyl-N,N'-bisacylpiperazine als Neurokininrezeptorantagonisten
ES2003830B3 (es) Procedimiento para fabricacion de derivados de imidazolil-metano
EP0990646A4 (de) Verfahren zur herstellung von 3-(7-amidino-2-naphthyl)-2-phenylpropionsäure-derivaten
DE69316112T2 (de) Immunoassays unter Verwendung von, mit Meerrettich-Peroxidase markierten Carbamazepin-Analogen
DE69711506T2 (de) Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung
ATE109479T1 (de) Verfahren zur herstellung von pyrimidinderivaten.
DE69612237D1 (de) Verfahren zur Herstellung von alpha-Methyl-2-thiophenessigsäure-Derivaten
FI955282A (fi) Menetelmä NG-monoalkyyli-L-arginiinin ja vastaavien yhdisteiden valmistamiseksi
ES8607237A1 (es) Procedimiento de preparacion y purificacion de un diester asimetrico.
ES8604501A2 (es) Procedimiento de obtencion de sulfonamidinas
BR8905907A (pt) Processo para a preparacao de um composto
SE8804516D0 (sv) Aminsalt

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: LES LABORATOIRES SERVIER, NEUILLY SUR SEINE, FR

8339 Ceased/non-payment of the annual fee